All News

There has been an increased focus on making healthcare price information more transparent, but with only price information, patients and payers have no way to determine if paying a higher price is warranted.

Social determinants have a major impact on health outcomes-especially for the most vulnerable populations. Factors such as a patient's education, income level, and environment must be considered when providing treatment and care.

The departure of UnitedHealth from most Affordable Care Act exchanges will have a relatively small effect on premiums across the country, but the effect could be more pronounced in rural areas and southern states.

Insurance plans offered through the Affordable Care Act are placing fewer drugs on the specialty tier of formularies than they were 2 years prior, according to a new study from Avalere.

This week in managed care included takeaways from the annual meeting of AMCP, the Supreme Court hears arguments regarding drug patent review, and CMS updates Medicaid managed care rules.

Overall use of a web-based tool providing real-time, personalized episode-level price estimates for healthcare was low, but for some procedures the number of people searching for prices of services was high relative to the number of people who received the service.

Oral anticancer agents are being launched at significantly higher prices compared with a decade ago, which can prove a barrier to patient access, according to a new analysis published in JAMA Oncology.

Our peer-reviewed research, featured recently in healthcare and mainstream news reports.

This sweeping proposal is the biggest step yet in shifting reimbursement from a volume-based to a value-based system. Stakeholders offered mixed opinions this week.

What We’re Reading, April 29, 2016: While sales of Gilead's Harvoni drop, NY state attorney's decision could be good news for the company; and the FDA faces a lawsuit from a consumer advocacy group.

What we're reading, April 28, 2016: Valeant officials express remorse over price hikes of heart drugs; Paul Ryan proposes placing consumers with serious medical conditions in high-risk pools; and a British medical organization is urging smokers to switch to e-cigarettes.

Patients whose hospital care providers used mobile secure text messaging to communicate had shorter hospital stays compared with patients whose health providers used standard paging systems to communicate.

A small study in 30 patients with advanced B-cell acute lymphoblastic leukemia has further strengthened the faith in the potential of chimeric antigen receptor or CAR-T cell therapy.

Unlike its closest rival, CVS Health, Express Scripts does not have a retail healthcare delivery infrastructure.

One leading expert called the proposal the most substantive change in decades, but some feared CMS is once again hastening the demise of the independent physician.

A company in Canada, Biolyse Pharma, has offered to manufacture a generic version of enzalutamide at a significantly lower price than what CMS paid in 2014.

A collaboration between the Dana-Farber Cancer Institute and the fitness tracking company Fitbit will investigate whether weight loss in women diagnosed with breast cancer can stave off recurrence.

A new study found that public understanding of the role of evidence-based care is equally as important as the medical evidence.

Two years after CDC heralded a drop in obesity rates among the youngest children, authors of a new study say it's too soon to declare victory.

The study team previously published research that linked diabetes to elevated rates of certain cancers.

What we're reading, April 27, 2016: Hawaii passes bill to protect transgender patients; childhood obesity has plateaued, not declined; and HHS awards $5 million to Puerto Rico to fight the Zika virus.

An exhaustive analysis of over a 100,000 individuals has confirmed the absence of unbiased association between statin use and a person’s risk of colorectal cancer; however, an inverse relation of risk and cholesterol levels was identified.

Two posters presented at the AMCP Managed Care & Specialty Pharmacy Annual Meeting evaluated opioid misuse and healthcare utilization and cost, as well as a program to flag potential misuse early.

The FDA issued a warning on the SGLT2 inhibitor class in May 2015, but the review by AACE and ACE found that several of the cases involved patients with type 1 disease.

The rule creates the first public reporting system of quality for Medicaid managed care plans.

A randomized, double-blind, placebo-controlled study conducted across 16 countries over a 3-year period has confirmed that Chantix and Zyban do not increase the risk of suicidal behavior among users.

What we're reading, April 26, 2016: the Supreme Court could rule for new process of reviewing drug patents; new Medicaid rules announced; 7 New York insurers will expand coverage of hepatitis C drugs.

Many Americans do not believe there is an association between price and quality in healthcare, according to a study published in Health Affairs.

For optimum utilization of consumer healthcare markets, physicians need to be prepared to help patients navigate out-of-pocket expenses during clinical encounters, researchers found.